MediSpan (Drug Discovery) is Drug Discovery in South Korea that focus on geriatric disease business. Founded in 2020. They cover business area such as developer, medical therapy, age improvement and geriatric disease treatment, drug, various senile disease, immunomodulatory function, patented substance, patient, ageing, health-life extension.
2020
( 4 years old in 2024 )
Geriatric Disease
-
Innovalley B-803, Pangyo-ro 253, Bundang-gu
Gyeonggi-do
Seongnam
South Korea
Private
developermedical therapyage improvement and geriatric disease treatmentdrugvarious senile diseaseimmunomodulatory functionpatented substancepatientageinghealth-life extension
* We use standard office opening hours in near MediSpan (Drug Discovery)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MediSpan (Drug Discovery) is Drug Discovery business from South Korea that founded in 2020 (4 years old in 2024), MediSpan (Drug Discovery) business is focusing on Geriatric Disease.
MediSpan (Drug Discovery) headquarter office and corporate office address is located in Innovalley B-803, Pangyo-ro 253, Bundang-gu Gyeonggi-do Seongnam South Korea.
MediSpan (Drug Discovery) was founded in South Korea.
In 2024, MediSpan (Drug Discovery) is currently focus on geriatric disease sector.
Above is snippet of Google Trends for "geriatric disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MediSpan (Drug Discovery), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
